Aurobindo recalls 22 batches of hypertensive drug in US citing cancer risk

According to a notification by the American drug regulator on its website, these 22 batches of Irbesartan drug substance were supplied by the city-based Aurobindo to ScieGen Pharmaceuticals Inc

from Latest News https://ift.tt/2PHrAny
https://ift.tt/eA8V8J https://ift.tt/2LUVdkd

• Tweet
• Share
• Share
• Share
• Share